Vertex Pharmaceuticals Incorporated

11/12/2021 | Press release | Distributed by Public on 11/12/2021 06:35

Vertex Receives CHMP Positive Opinion for KAFTRIO® (ivacaftor/tezacaftor/elexacaftor) in Combination With Ivacaftor in Children With Cystic Fibrosis Ages 6 Through 11